Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
Ironwood Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 21, 2022
Ironwood Pharmaceuticals reported fiscal year 2021 executive compensation information on April 21, 2022.
In 2021, seven executives at Ironwood Pharmaceuticals received on average a compensation package of $3.4M, which is about the same as previous year.
Average pay of disclosed executives at Ironwood Pharmaceuticals
Thomas A. McCourt, Chief Executive Officer, received $8.8M in total, which increased by 158% compared to 2020. 82% of McCourt's compensation, or $7.2M, was in stock awards. McCourt also received $143K in bonus, $680K in non-equity incentive plan, $732K in salary, as well as $18K in other compensation.
Jason Rickard, Chief Operating Officer, received a compensation package of $3.5M, which increased by 57% compared to previous year. 72% of the compensation package, or $2.5M, was in stock awards.
John Minardo, Chief Legal Officer, earned $3.1M in 2021.
Gina Consylman, Chief Financial Officer, received $2.8M in 2021, which increases by 13% compared to 2020.
Michael Shetzline, Chief Medical Officer, earned $2.6M in 2021, a 39% increase compared to previous year.
Sravan Emany, Chief Financial Officer, received $2.5M in 2021.
Mark Mallon, Chief Executive Officer, earned $171K in 2021, a 97% decrease compared to previous year.
Related executives
Thomas McCourt
Ironwood Pharmaceuticals
Chief Executive Officer
Sravan Emany
Ironwood Pharmaceuticals
Chief Financial Officer
John Minardo
Ironwood Pharmaceuticals
Chief Legal Officer
Jason Rickard
Ironwood Pharmaceuticals
Chief Operating Officer
Michael Shetzline
Ironwood Pharmaceuticals
Chief Medical Officer
Mark Mallon
Ironwood Pharmaceuticals
Chief Executive Officer
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
You may also like
Source: SEC filing on April 21, 2022.